The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Sufentanil (API)-Global Market Insights and Sales Trends 2024
Synopsis
Sufentanil, sold under the brand names Dsuvia and Sufenta, is a synthetic opioid analgesic drug approximately 5 to 10 times as potent as its parent drug, fentanyl, and 500 times as potent as morphine.
The global Sufentanil (API) market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Sufentanil (API) in various end use industries. The expanding demands from the Injection and Capsule, are propelling Sufentanil (API) market. Purity 98%, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Purity 99% segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Sufentanil (API) market, driven by demand from China, the second largest economy with some signs of stabilising, the Sufentanil (API) market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Sufentanil (API), with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Sufentanil (API) market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Sufentanil (API) market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Sufentanil (API) sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Sufentanil (API) covered in this report include Kern Pharma, Cambrex, Hameln Rds, Cristalia and Janssen Pharmaceuticals, etc.
The global Sufentanil (API) market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Kern Pharma
Cambrex
Hameln Rds
Cristalia
Janssen Pharmaceuticals
Global Sufentanil (API) market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Sufentanil (API) market, Segment by Type:
Purity 98%
Purity 99%
Global Sufentanil (API) market, by Application
Injection
Capsule
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Sufentanil (API) manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Sufentanil (API) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Sufentanil, sold under the brand names Dsuvia and Sufenta, is a synthetic opioid analgesic drug approximately 5 to 10 times as potent as its parent drug, fentanyl, and 500 times as potent as morphine.
The global Sufentanil (API) market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Sufentanil (API) in various end use industries. The expanding demands from the Injection and Capsule, are propelling Sufentanil (API) market. Purity 98%, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Purity 99% segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Sufentanil (API) market, driven by demand from China, the second largest economy with some signs of stabilising, the Sufentanil (API) market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Sufentanil (API), with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Sufentanil (API) market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Sufentanil (API) market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Sufentanil (API) sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Sufentanil (API) covered in this report include Kern Pharma, Cambrex, Hameln Rds, Cristalia and Janssen Pharmaceuticals, etc.
The global Sufentanil (API) market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Kern Pharma
Cambrex
Hameln Rds
Cristalia
Janssen Pharmaceuticals
Global Sufentanil (API) market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Sufentanil (API) market, Segment by Type:
Purity 98%
Purity 99%
Global Sufentanil (API) market, by Application
Injection
Capsule
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Sufentanil (API) manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Sufentanil (API) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Sufentanil (API) Market Overview
1.1 Sufentanil (API) Product Overview
1.2 Sufentanil (API) Market Segment by Type
1.2.1 Purity 98%
1.2.2 Purity 99%
1.3 Global Sufentanil (API) Market Size by Type
1.3.1 Global Sufentanil (API) Market Size Overview by Type (2018-2029)
1.3.2 Global Sufentanil (API) Historic Market Size Review by Type (2018-2023)
1.3.3 Global Sufentanil (API) Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Sufentanil (API) Sales Breakdown by Type (2018-2023)
1.4.2 Europe Sufentanil (API) Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Sufentanil (API) Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Sufentanil (API) Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Sufentanil (API) Sales Breakdown by Type (2018-2023)
2 Global Sufentanil (API) Market Competition by Company
2.1 Global Top Players by Sufentanil (API) Sales (2018-2023)
2.2 Global Top Players by Sufentanil (API) Revenue (2018-2023)
2.3 Global Top Players by Sufentanil (API) Price (2018-2023)
2.4 Global Top Manufacturers Sufentanil (API) Manufacturing Base Distribution, Sales Area, Product Type
2.5 Sufentanil (API) Market Competitive Situation and Trends
2.5.1 Sufentanil (API) Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Sufentanil (API) Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Sufentanil (API) as of 2022)
2.7 Date of Key Manufacturers Enter into Sufentanil (API) Market
2.8 Key Manufacturers Sufentanil (API) Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Sufentanil (API) Status and Outlook by Region
3.1 Global Sufentanil (API) Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Sufentanil (API) Historic Market Size by Region
3.2.1 Global Sufentanil (API) Sales in Volume by Region (2018-2023)
3.2.2 Global Sufentanil (API) Sales in Value by Region (2018-2023)
3.2.3 Global Sufentanil (API) Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Sufentanil (API) Forecasted Market Size by Region
3.3.1 Global Sufentanil (API) Sales in Volume by Region (2024-2029)
3.3.2 Global Sufentanil (API) Sales in Value by Region (2024-2029)
3.3.3 Global Sufentanil (API) Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Sufentanil (API) by Application
4.1 Sufentanil (API) Market Segment by Application
4.1.1 Injection
4.1.2 Capsule
4.2 Global Sufentanil (API) Market Size by Application
4.2.1 Global Sufentanil (API) Market Size Overview by Application (2018-2029)
4.2.2 Global Sufentanil (API) Historic Market Size Review by Application (2018-2023)
4.2.3 Global Sufentanil (API) Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Sufentanil (API) Sales Breakdown by Application (2018-2023)
4.3.2 Europe Sufentanil (API) Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Sufentanil (API) Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Sufentanil (API) Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Sufentanil (API) Sales Breakdown by Application (2018-2023)
5 North America Sufentanil (API) by Country
5.1 North America Sufentanil (API) Historic Market Size by Country
5.1.1 North America Sufentanil (API) Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Sufentanil (API) Sales in Volume by Country (2018-2023)
5.1.3 North America Sufentanil (API) Sales in Value by Country (2018-2023)
5.2 North America Sufentanil (API) Forecasted Market Size by Country
5.2.1 North America Sufentanil (API) Sales in Volume by Country (2024-2029)
5.2.2 North America Sufentanil (API) Sales in Value by Country (2024-2029)
6 Europe Sufentanil (API) by Country
6.1 Europe Sufentanil (API) Historic Market Size by Country
6.1.1 Europe Sufentanil (API) Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Sufentanil (API) Sales in Volume by Country (2018-2023)
6.1.3 Europe Sufentanil (API) Sales in Value by Country (2018-2023)
6.2 Europe Sufentanil (API) Forecasted Market Size by Country
6.2.1 Europe Sufentanil (API) Sales in Volume by Country (2024-2029)
6.2.2 Europe Sufentanil (API) Sales in Value by Country (2024-2029)
7 Asia-Pacific Sufentanil (API) by Region
7.1 Asia-Pacific Sufentanil (API) Historic Market Size by Region
7.1.1 Asia-Pacific Sufentanil (API) Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Sufentanil (API) Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Sufentanil (API) Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Sufentanil (API) Forecasted Market Size by Region
7.2.1 Asia-Pacific Sufentanil (API) Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Sufentanil (API) Sales in Value by Region (2024-2029)
8 Latin America Sufentanil (API) by Country
8.1 Latin America Sufentanil (API) Historic Market Size by Country
8.1.1 Latin America Sufentanil (API) Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Sufentanil (API) Sales in Volume by Country (2018-2023)
8.1.3 Latin America Sufentanil (API) Sales in Value by Country (2018-2023)
8.2 Latin America Sufentanil (API) Forecasted Market Size by Country
8.2.1 Latin America Sufentanil (API) Sales in Volume by Country (2024-2029)
8.2.2 Latin America Sufentanil (API) Sales in Value by Country (2024-2029)
9 Middle East and Africa Sufentanil (API) by Country
9.1 Middle East and Africa Sufentanil (API) Historic Market Size by Country
9.1.1 Middle East and Africa Sufentanil (API) Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Sufentanil (API) Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Sufentanil (API) Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Sufentanil (API) Forecasted Market Size by Country
9.2.1 Middle East and Africa Sufentanil (API) Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Sufentanil (API) Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Kern Pharma
10.1.1 Kern Pharma Company Information
10.1.2 Kern Pharma Introduction and Business Overview
10.1.3 Kern Pharma Sufentanil (API) Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Kern Pharma Sufentanil (API) Products Offered
10.1.5 Kern Pharma Recent Development
10.2 Cambrex
10.2.1 Cambrex Company Information
10.2.2 Cambrex Introduction and Business Overview
10.2.3 Cambrex Sufentanil (API) Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Cambrex Sufentanil (API) Products Offered
10.2.5 Cambrex Recent Development
10.3 Hameln Rds
10.3.1 Hameln Rds Company Information
10.3.2 Hameln Rds Introduction and Business Overview
10.3.3 Hameln Rds Sufentanil (API) Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Hameln Rds Sufentanil (API) Products Offered
10.3.5 Hameln Rds Recent Development
10.4 Cristalia
10.4.1 Cristalia Company Information
10.4.2 Cristalia Introduction and Business Overview
10.4.3 Cristalia Sufentanil (API) Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Cristalia Sufentanil (API) Products Offered
10.4.5 Cristalia Recent Development
10.5 Janssen Pharmaceuticals
10.5.1 Janssen Pharmaceuticals Company Information
10.5.2 Janssen Pharmaceuticals Introduction and Business Overview
10.5.3 Janssen Pharmaceuticals Sufentanil (API) Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Janssen Pharmaceuticals Sufentanil (API) Products Offered
10.5.5 Janssen Pharmaceuticals Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Sufentanil (API) Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Sufentanil (API) Industrial Chain Analysis
11.4 Sufentanil (API) Market Dynamics
11.4.1 Sufentanil (API) Industry Trends
11.4.2 Sufentanil (API) Market Drivers
11.4.3 Sufentanil (API) Market Challenges
11.4.4 Sufentanil (API) Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Sufentanil (API) Distributors
12.3 Sufentanil (API) Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
